HealthLeaders Media June 6, 2022
Christopher Cheney

Researchers show that pulse oximetry, which is a gatekeeper in treatment decisions for COVID-19 patients, overestimates blood oxygen levels in people of color.

KEY TAKEAWAYS

– When compared to White COVID-19 patients, pulse oximetry overestimated blood oxygen levels by 1.7% for Asian patients, 1.2% for Black patients, and 1.1% for non-Black Hispanic patients.

– Compared to White COVID-19 patients, Black patients were 29% less likely to have their treatment eligibility recognized by pulse oximetry and non-Black Hispanic patients were 23% less likely to have their treatment eligibility recognized by pulse oximetry.

In a new study involving more than 7,000 COVID-19 patients, pulse oximeter devices overestimated blood oxygen levels in Asian, Black, and non-Black Hispanic patients, which could have affected their...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Healthcare System, Patient / Consumer, Provider, Public Health / COVID, Survey / Study, Technology, Trends, Wearables
Shifting Our Healthcare Delivery Model from Reactive to Proactive
Medtronic, Tempus testing AI to find potential TAVR patients
Why Tufts Medicine ended its hospital-at-home program
How the Triadic Model of Interpreter, Patient and Provider has Elevated Healthcare Communications
Is a lack of understanding driving alcohol-related deaths in the U.S.?

Share This Article